vs
MEDICAL PROPERTIES TRUST INC（MPW）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
MEDICAL PROPERTIES TRUST INC的季度营收约是REPLIGEN CORP的1.4倍（$270.3M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs 6.5%，领先0.2%），MEDICAL PROPERTIES TRUST INC同比增速更快（16.6% vs 13.6%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -0.2%）
Medical Properties Trust, Inc.（MPT）是一家总部位于美国阿拉巴马州伯明翰的跨国房地产投资信托基金（REIT），主要在美欧地区收购、投资医疗保健设施与营利性医疗控股公司，资产收购多采用售后回租模式，原业主出售资产后成为其租户，租户通常需签署长期三净租赁协议。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
MPW vs RGEN — 直观对比
营收规模更大
MPW
是对方的1.4倍
$197.9M
营收增速更快
MPW
高出3.0%
13.6%
净利率更高
RGEN
高出0.2%
6.5%
两年增速更快
RGEN
近两年复合增速
-0.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $270.3M | $197.9M |
| 净利润 | $17.6M | $13.3M |
| 毛利率 | 95.8% | 52.5% |
| 营业利润率 | 9.7% | 9.0% |
| 净利率 | 6.5% | 6.7% |
| 营收同比 | 16.6% | 13.6% |
| 净利润同比 | 104.3% | 143.9% |
| 每股收益（稀释后） | $0.03 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MPWRGEN
| Q4 25 | $270.3M | $197.9M | ||
| Q3 25 | $237.5M | $188.8M | ||
| Q2 25 | $240.4M | $182.4M | ||
| Q1 25 | $223.8M | $169.2M | ||
| Q4 24 | $231.8M | $174.1M | ||
| Q3 24 | $225.8M | $154.9M | ||
| Q2 24 | $266.6M | $154.1M | ||
| Q1 24 | $271.3M | $151.3M |
净利润MPWRGEN
| Q4 25 | $17.6M | $13.3M | ||
| Q3 25 | $-77.7M | $14.9M | ||
| Q2 25 | $-98.4M | $14.9M | ||
| Q1 25 | $-118.3M | $5.8M | ||
| Q4 24 | $-412.3M | $-30.3M | ||
| Q3 24 | $-801.2M | $-654.0K | ||
| Q2 24 | $-320.6M | $3.3M | ||
| Q1 24 | $-875.6M | $2.1M |
毛利率MPWRGEN
| Q4 25 | 95.8% | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | 91.8% | 50.0% | ||
| Q1 25 | 63.6% | 53.6% | ||
| Q4 24 | 90.9% | 26.1% | ||
| Q3 24 | 96.5% | 50.0% | ||
| Q2 24 | 98.4% | 49.8% | ||
| Q1 24 | 84.9% | 49.5% |
营业利润率MPWRGEN
| Q4 25 | 9.7% | 9.0% | ||
| Q3 25 | -28.0% | 8.9% | ||
| Q2 25 | -36.7% | 7.6% | ||
| Q1 25 | -48.5% | 3.9% | ||
| Q4 24 | -173.7% | -17.7% | ||
| Q3 24 | -350.7% | -5.1% | ||
| Q2 24 | -114.5% | 1.0% | ||
| Q1 24 | -318.6% | 1.3% |
净利率MPWRGEN
| Q4 25 | 6.5% | 6.7% | ||
| Q3 25 | -32.7% | 7.9% | ||
| Q2 25 | -40.9% | 8.2% | ||
| Q1 25 | -52.8% | 3.4% | ||
| Q4 24 | -177.8% | -17.4% | ||
| Q3 24 | -354.8% | -0.4% | ||
| Q2 24 | -120.3% | 2.2% | ||
| Q1 24 | -322.7% | 1.4% |
每股收益（稀释后）MPWRGEN
| Q4 25 | $0.03 | $0.24 | ||
| Q3 25 | $-0.13 | $0.26 | ||
| Q2 25 | $-0.16 | $0.26 | ||
| Q1 25 | $-0.20 | $0.10 | ||
| Q4 24 | $-0.68 | $-0.55 | ||
| Q3 24 | $-1.34 | $-0.01 | ||
| Q2 24 | $-0.54 | $0.06 | ||
| Q1 24 | $-1.46 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $540.9M | $767.6M |
| 总债务越低越好 | $9.7B | $542.2M |
| 股东权益账面价值 | $4.6B | $2.1B |
| 总资产 | $15.0B | $2.9B |
| 负债/权益比越低杠杆越低 | 2.11× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资MPWRGEN
| Q4 25 | $540.9M | $767.6M | ||
| Q3 25 | $396.6M | $748.7M | ||
| Q2 25 | $509.8M | $708.9M | ||
| Q1 25 | $673.5M | $697.2M | ||
| Q4 24 | $332.3M | $757.4M | ||
| Q3 24 | $275.6M | $784.0M | ||
| Q2 24 | $606.5M | $809.1M | ||
| Q1 24 | $224.3M | $780.6M |
总债务MPWRGEN
| Q4 25 | $9.7B | $542.2M | ||
| Q3 25 | $9.6B | $537.9M | ||
| Q2 25 | $9.6B | — | ||
| Q1 25 | $9.5B | — | ||
| Q4 24 | $8.8B | $525.6M | ||
| Q3 24 | $9.2B | — | ||
| Q2 24 | $9.4B | — | ||
| Q1 24 | $10.1B | — |
股东权益MPWRGEN
| Q4 25 | $4.6B | $2.1B | ||
| Q3 25 | $4.7B | $2.1B | ||
| Q2 25 | $4.8B | $2.1B | ||
| Q1 25 | $4.8B | $2.0B | ||
| Q4 24 | $4.8B | $2.0B | ||
| Q3 24 | $5.4B | $2.0B | ||
| Q2 24 | $6.2B | $2.0B | ||
| Q1 24 | $6.7B | $2.0B |
总资产MPWRGEN
| Q4 25 | $15.0B | $2.9B | ||
| Q3 25 | $14.9B | $2.9B | ||
| Q2 25 | $15.2B | $2.9B | ||
| Q1 25 | $14.9B | $2.9B | ||
| Q4 24 | $14.3B | $2.8B | ||
| Q3 24 | $15.2B | $2.8B | ||
| Q2 24 | $16.2B | $2.9B | ||
| Q1 24 | $17.3B | $2.8B |
负债/权益比MPWRGEN
| Q4 25 | 2.11× | 0.26× | ||
| Q3 25 | 2.06× | 0.26× | ||
| Q2 25 | 2.00× | — | ||
| Q1 25 | 1.99× | — | ||
| Q4 24 | 1.83× | 0.27× | ||
| Q3 24 | 1.69× | — | ||
| Q2 24 | 1.51× | — | ||
| Q1 24 | 1.51× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $230.8M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | 13.11× | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流MPWRGEN
| Q4 25 | $230.8M | $25.7M | ||
| Q3 25 | $18.6M | $48.1M | ||
| Q2 25 | $51.7M | $28.6M | ||
| Q1 25 | $384.0K | $15.0M | ||
| Q4 24 | $245.5M | $39.2M | ||
| Q3 24 | $59.2M | $49.3M | ||
| Q2 24 | $35.3M | $42.2M | ||
| Q1 24 | $74.3M | $44.7M |
自由现金流MPWRGEN
| Q4 25 | — | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | — | $37.4M | ||
| Q1 24 | — | $36.4M |
自由现金流率MPWRGEN
| Q4 25 | — | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 24.3% | ||
| Q1 24 | — | 24.0% |
资本支出强度MPWRGEN
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 5.5% |
现金转化率MPWRGEN
| Q4 25 | 13.11× | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
